NLS Denmark

This up-and-coming star on the global biotech scene aims to crack the hard code of finding better treatments for neurodegenerative diseases. The name of the company, Muna, means “to remember” in Old Norse and reflects the focus of discovering and developing medicines for neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Multiple Sclerosis and Frontotemporal Dementia. These are […]

The center will be the seventh specialized diabetes centre supported by the Novo Nordisk Foundation. A Steno Diabetes Center has been established in each of the five administrative regions in Denmark and one in Greenland, and now all the Danish realm is covered. They aim to ensure that people with diabetes have access to the […]

Denmark and Sweden are the two leading life science nations of the Nordics, and both countries rank in the top-10 of most innovative countries in the world1. Coming together in the Medicon Valley region around Øresund they have created the largest, most vibrant, and most attractive life science cluster in the European Union. Although this […]

The Novo Nordisk Foundation (NNF) has awarded a 195  million DKK grant for establishing a national, brickless Danish Diabetes and Endocrine Academy (DDEA) with an executive office based at Odense University Hospital. The purpose of the Academy is to develop and strengthen the quality of Danish diabetes and endocrine research and research-based education. The Academy […]

Anders Findsen likes to be part of the different R&D aspects of an up-and-coming dynamic biotech company. As Research Scientist at NMD Pharma he gets to follow a compound from the beginning to hopefully going into the clinic in the end.

When celebrating it’s 10-year anniversary next year, the conference organizers of NLSDays have decided to try out Copenhagen and the newly renovated Bella Centre for the first time. After several years in Stockholm only and a handful of years in either Stockholm or Malmö, where NLSDays will be held September this year, SwedenBIO and the […]